Covered stent placement in patients with recurrent cancer after a Billroth I reconstruction

J Vasc Interv Radiol. 2007 Dec;18(12):1533-7. doi: 10.1016/j.jvir.2007.07.025.

Abstract

Purpose: To assess the technical feasibility and clinical effectiveness of covered stent placement in patients with recurrent malignant obstructions after Billroth I reconstruction.

Materials and methods: From June 1997 to November 2005, 16 patients underwent covered stent placement for recurrent gastric cancer after Billroth I reconstruction. A total of 19 covered stents were used, including 14 dual stents and five fully covered stents, as available.

Results: Stent placement was technically successful in all patients, with 13 of 16 patients (81%) showing improvement of symptoms. Stent migration occurred in one patient, tumor ingrowth in one, and stent collapse and/or bowel perforation in one. Nine patients (56%) had concomitant (n=7) or subsequent (n=2) biliary obstruction. One patient was lost to follow-up. The remaining 15 patients died 5-628 days (median, 52 days; mean, 120 days) after stent placement due to progression of disease or pneumonia.

Conclusions: Placement of covered metallic stents is feasible and effective in patients with recurrent malignant obstruction after Billroth I reconstruction.

MeSH terms

  • Adult
  • Aged
  • Duodenal Obstruction / etiology
  • Duodenal Obstruction / therapy*
  • Endoscopy, Gastrointestinal
  • Feasibility Studies
  • Female
  • Fluoroscopy
  • Follow-Up Studies
  • Gastroenterostomy*
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / complications
  • Neoplasm Recurrence, Local / therapy*
  • Stents* / adverse effects
  • Stomach Neoplasms / complications
  • Stomach Neoplasms / surgery
  • Stomach Neoplasms / therapy*
  • Treatment Outcome